In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.

Saved in:
Bibliographic Details
Title: In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
Authors: Rorick-Kehn, Linda M.1 RorickKehnLM@lilly.com, Johnson, Bryan G.1, Knitowski, Karen M.1, Salhoff, Craig R.1, Witkin, Jeffrey M.1, Perry, Kenneth W.1, Griffey, Kelly I.1, Tizzano, Joseph P.2, Monn, James A.1, McKinzie, David L.1, Schoepp, Darryle D.1
Source: Psychopharmacology. Jul2007, Vol. 193 Issue 1, p121-136.
Database: SPORTDiscus with Full Text
Description
ISSN:00333158
DOI:10.1007/s00213-007-0758-3